56 results
Page 2 of 3
8-K
owgyzm evojzu
5 Dec 22
Other Events
6:47am
8-K
EX-99.1
a3r gnv3lfzz4x1j0
7 Nov 22
Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results
7:00am
8-K
EX-99.1
ed8pkn ntmgb3hsg3
9 Aug 22
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results
6:45am
8-K
EX-1.1
80dw0b
21 Jul 22
Verve Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
4:46pm
424B5
xdu2g
21 Jul 22
Prospectus supplement for primary offering
4:43pm
424B5
dm64s5b5
20 Jul 22
Prospectus supplement for primary offering
4:22pm
8-K
kthial5y rtzuhll
12 Jul 22
Other Events
7:00am
S-3
EX-1.2
zcdl39 124
1 Jul 22
Shelf registration
4:36pm
10-K
hgb9xktm 7oprx
14 Mar 22
Annual report
7:04am
8-K
EX-99.1
fdduhx14rwvndhcpnrtf
14 Mar 22
Verve Therapeutics Announces Pipeline Progress and Reports Fourth Quarter and Full Year 2021 Financial Results
6:49am
10-Q
q41y977axqzixizo
12 Aug 21
Quarterly report
8:53am
8-K
EX-3.2
ccv 47xbchexem9y
21 Jun 21
Amendments to Articles of Incorporation or Bylaws
5:06pm